DGAP-News: Novavax to Report Fourth Quarter and Year-End 2013 Financial Results on March 10, 2014

        Print
| Source: EQS Group AG
DGAP-News: Novavax, Inc. /
Novavax to Report Fourth Quarter and Year-End 2013 Financial Results
on March 10, 2014

19.02.2014 / 22:43

---------------------------------------------------------------------

ROCKVILLE, Md., 2014-02-19 22:43 CET (GLOBE NEWSWIRE) --
Novavax, Inc. (Nasdaq:NVAX) announced today that it will host a conference call
and webcast to report its fourth quarter and year-end 2013 financial results on
Monday, March 10, 2014, at 4:30 p.m. ET. 

The dial-in number for the conference call is 1 (877) 212-6076 (U.S. or Canada)
or 1 (707) 287-9331 (international). A webcast of the conference call can also
be accessed via a link on the home page of the Novavax website (novavax.com) or
through the 'Investor Info'/'Events' tab on the Novavax website. 

A replay of the conference call will be available from 7:30 pm on March 10,
2014 until midnight May 1, 2014. To access the replay by telephone, dial 1
(855) 859-2056 (domestic) or 1 (404) 537-3406 (international) and use passcode
2459615. The replay will also be available as a webcast and can be found on the
'Investor Info'/'Events' on the Novavax website. 

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company
creating novel vaccines and vaccine adjuvants to address a broad range of
infectious diseases worldwide. Using innovative proprietary recombinant protein
nanoparticle vaccine technology, the company produces vaccine candidates to
efficiently and effectively respond to both known and newly emergent diseases.
Additional information about Novavax is available on the company's website,
novavax.com. 

CONTACT: Barclay PhillipsSVP, Chief Financial Officer and TreasurerNovavax,
Inc.240-268-2000
News Source: NASDAQ OMX


End of Corporate News

---------------------------------------------------------------------

19.02.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------


Language:    English        
Company:     Novavax, Inc.  
 
 
             United States  
ISIN:        US6700021040   
 
 
End of News    DGAP News-Service  
---------------------------------------------------------------------  
253416 19.02.2014